Leadership

Patrick Van Beneden, MS

Board Member

Representing Fund+ Patrick Van Beneden has nearly 40 years of experience in life science focused venture capital, including a 35-year tenure with the European investment group Gimv. His former board of director seats include; Innogenetics, Devgen, Crop Design, Crucell, Prosensa, Ablynx, Endosense, Astex, Plexxikon, Onward, Jena Valve and Fire1. He currently works as a consultant in the life science sector and serves as board member for Biotalys (listed on Euronext), Novadip and Minoryx.